Dendreon (DNDN) Inventory Turnover Ratio, from third quarter 2014 to third quarter 2013, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Dendreon Corp  (DNDN)
 

Dendreon Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Dendreon Corp inventory turnover ratio, the Dendreon Corp's ability to sell and replace its inventory in the third quarter 2014, sequentially increased to 2.34 in the third quarter 2014, yet the ratio remained below the average, as DNDN's market remain challenging.Average inventory processing period, for the Dendreon in Sep 30 2014 quarter, has decreased to 156 days, compare to 162 days, in the Jun 30 2014 quarter.

Within Healthcare sector 183 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2014, to 1492, from total ranking in the second quarter 2014 at 1646.

DNDN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Dendreon Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DNDN Inventory Turnover Ratio (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter
Y / Y Inventory Growth -30.88 % -23.38 % -29.39 % -28.77 % 40.12 %
Y / Y Cost of Sales Growth -24.15 % -13.53 % -15.55 % -29.23 % -9.31 %
Inventory Turnover Ratio (TTM) 2.34 2.25 2.17 2.08 2.13
DNDN's Total Ranking # 1492 # 1646 # 1527 # 1498 # 1724
Average inventory processing period 156 162 168 175 171
Seq. Inventory Growth -5.14 % 10.77 % 16.33 % -43.46 % 5.17 %
Seq. Cost of Sales Growth -6 % 3.39 % -4.8 % -18.02 % 7.16 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 13
Healthcare Sector # 184
Overall Market # 1492

Inventory Turnover Ratio Statistics
High Average Low
3.33 2.6 2.08
(Jun 30 2012)   (Dec 31 2013)



DNDN Company Profile >> Back to DNDN Efficiency Comparisons >> Compare DNDN Inventory Turnover Ratio to its Competitors

Financial Statements
Dendreon's Inventories $ 66 Millions Visit DNDN's Balance sheet
Dendreon's Cost of Revenues TTM $ 149 Millions Visit DNDN's Income Statement
What are DNDN's Sales? Visit DNDN's Sales by Segment

Other Inventory Turnover Ratios
Dendreon's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
DNDN's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for DNDN's Competitors
Inventory Turnover Ratio for DNDN's Suppliers
Inventory Turnover Ratio for DNDN's Customers

You may also want to know
DNDN's Sales Growth Rates DNDN's Pe Price to earnings ratio DNDN's Receivables Turnover Ratio DNDN's Stock Quote
DNDN's Net Income Growth Rates DNDN's Ps Price to Sales ratio DNDN's Sales per Employee DNDN's Asset Turnover Ratio
DNDN's Net Margin DNDN's Pb Price to Book ratio DNDN's Financial Strength Ratios DNDN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2014 Inventories at quarter ending Sep 30 2014
Integrated Biopharma Inc  6.14 $ 35.509  Millions$ 6  Millions
Biorestorative Therapies Inc   6.11 $ 0.109  Millions$ 0  Millions
Steris Plc  6.09 $ 1,033.855  Millions$ 170  Millions
Charles River Laboratories International inc   5.93 $ 543.459  Millions$ 92  Millions
Fibrocell Science, Inc.  5.93 $ 3.244  Millions$ 1  Millions
Myriad Genetics Inc   5.92 $ 107.498  Millions$ 18  Millions
Carlisle Companies Incorporated  5.68 $ 1,828.300  Millions$ 322  Millions
Teligent Inc   5.49 $ 15.750  Millions$ 3  Millions
Medifirst Solutions, Inc.  5.42 $ 0.048  Millions$ 0  Millions
West Pharmaceutical Services Inc   5.33 $ 983.900  Millions$ 185  Millions
Invacare Holdings Corporation  5.18 $ 840.571  Millions$ 162  Millions
Lifeloc Technologies Inc   5.16 $ 4.666  Millions$ 1  Millions
Vertex Pharmaceuticals Inc  5.11 $ 69.224  Millions$ 14  Millions
Ligand Pharmaceuticals Incorporated  4.93 $ 6.450  Millions$ 1  Millions
Tearlab Corp  4.93 $ 9.713  Millions$ 2  Millions
Perrigo Company Plc  4.83 $ 3,242.613  Millions$ 671  Millions
Cyteir Therapeutics Inc   4.81 $ 1,337.600  Millions$ 278  Millions
Teva Pharmaceutical Industries Limited  4.64 $ 11,784.000  Millions$ 2,537  Millions
Chembio Diagnostics Inc   4.64 $ 17.236  Millions$ 4  Millions
Idexx Laboratories Inc  4.62 $ 665.306  Millions$ 144  Millions
Enzo Biochem Inc  4.45 $ 39.369  Millions$ 9  Millions
Nanostring Technologies Inc   4.40 $ 29.095  Millions$ 7  Millions
Heska Corporation  4.34 $ 52.941  Millions$ 12  Millions
Amarin Corp Plcuk  4.32 $ 18.736  Millions$ 4  Millions
Icu Medical Inc  4.26 $ 156.644  Millions$ 37  Millions
Igc Pharma Inc   4.17 $ 2.636  Millions$ 1  Millions
Pacira Biosciences inc   4.17 $ 76.848  Millions$ 18  Millions
Adicet Bio Inc   4.17 $ 403.101  Millions$ 97  Millions
Bausch Health Companies Inc   4.16 $ 2,896.230  Millions$ 697  Millions
3m Company  4.13 $ 16,396.000  Millions$ 3,969  Millions

Date modified: 2026-09-08T15:07:44+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.